Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-10
2006-10-10
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S365000
Reexamination Certificate
active
07119092
ABSTRACT:
whereinR represents a halogen atom or a C1-4alkyl group;R1represents a C1-4alkyl group;R2represents hydrogen or a C1-4alkyl group;R3represents hydrogen, or a C1-4alkyl group;R4represents a trifluoromethyl group;R5represents hydrogen, a C1-4alkyl group or C(O)R6;R6represents C1-4alkyl, C3-7cycloalkyl, NH(C1-4alkyl) or N(C1-4alkyl)2;m is zero or an integer from 1 to 3;n is an integer from 1 to 3 and pharmaceutically acceptable salts and solvates thereof; to processes for their preparation and their use in the treatment of conditions mediated by tachykinins.
REFERENCES:
patent: 4087424 (1978-05-01), Saikawa et al.
patent: 4110327 (1978-08-01), Saikawa et al.
patent: 4112090 (1978-09-01), Saikawa et al.
patent: 4219554 (1980-08-01), Saikawa et al.
patent: 4308387 (1981-12-01), Bjork et al.
patent: 4327097 (1982-04-01), Saikawa et al.
patent: 4379152 (1983-04-01), Saikawa et al.
patent: 4410522 (1983-10-01), Saikawa et al.
patent: 5028610 (1991-07-01), Hirai et al.
patent: 5109014 (1992-04-01), Jacobson
patent: 5334606 (1994-08-01), MacLeod
patent: 5348955 (1994-09-01), Greenlee et al.
patent: 5360820 (1994-11-01), Hagan et al.
patent: 5464788 (1995-11-01), Bock et al.
patent: 5538982 (1996-07-01), Hagan et al.
patent: 5563127 (1996-10-01), Amparo et al.
patent: 5576317 (1996-11-01), Gonsalves
patent: 5696123 (1997-12-01), Dollinger et al.
patent: 5698538 (1997-12-01), Amparo et al.
patent: 5708006 (1998-01-01), Dollinger et al.
patent: 5710169 (1998-01-01), Russell
patent: 5716942 (1998-02-01), Dorn et al.
patent: 5756504 (1998-05-01), Bock et al.
patent: 5814636 (1998-09-01), Katano et al.
patent: 5859015 (1999-01-01), Graham et al.
patent: 5883096 (1999-03-01), Lowe et al.
patent: 5935951 (1999-08-01), Ofner et al.
patent: 5952315 (1999-09-01), Baker et al.
patent: 5977104 (1999-11-01), Baker et al.
patent: 5985881 (1999-11-01), Dollinger et al.
patent: 5998444 (1999-12-01), Russell
patent: 6037352 (2000-03-01), Lowe et al.
patent: 6057323 (2000-05-01), Zhang et al.
patent: 6090807 (2000-07-01), Hellendahl et al.
patent: 6114315 (2000-09-01), Baker et al.
patent: 6117855 (2000-09-01), Carlson et al.
patent: 6147083 (2000-11-01), Russell
patent: 6191135 (2001-02-01), Dollinger et al.
patent: 6191139 (2001-02-01), Hagan
patent: 6197772 (2001-03-01), Janssens et al.
patent: 6235732 (2001-05-01), Dollinger et al.
patent: 6288068 (2001-09-01), Lowe et al.
patent: 6319953 (2001-11-01), Carlson et al.
patent: RE37886 (2002-10-01), Janssens et al.
patent: 6521621 (2003-02-01), Janssens et al.
patent: 6642240 (2003-11-01), Alvaro et al.
patent: 2002/0103205 (2002-08-01), Lowe et al.
patent: 2519400 (1978-04-01), None
patent: 287734 (1987-10-01), None
patent: 293532 (1987-10-01), None
patent: 0655442 (1995-05-01), None
patent: 718287 (1995-12-01), None
patent: 0721941 (1996-07-01), None
patent: 0655422 (2001-05-01), None
patent: 1508062 (1975-04-01), None
patent: 57/118587 (1982-07-01), None
patent: WO 92/16211 (1992-10-01), None
patent: WO 95/00498 (1995-01-01), None
patent: WO 95/25443 (1995-09-01), None
patent: WO 96/02503 (1996-02-01), None
patent: WO 96/03378 (1996-02-01), None
patent: WO 96/10562 (1996-04-01), None
patent: WO 96/14844 (1996-05-01), None
patent: WO 96/20173 (1996-07-01), None
patent: WO 97/16440 (1997-05-01), None
patent: WO 97/32865 (1997-09-01), None
patent: WO 97/36592 (1997-10-01), None
patent: WO 97/36593 (1997-10-01), None
patent: WO 97/36888 (1997-10-01), None
patent: WO 97/36889 (1997-10-01), None
patent: WO 98/01133 (1998-01-01), None
patent: WO 98/20001 (1998-05-01), None
patent: WO 98/57954 (1998-12-01), None
patent: WO 99/09985 (1999-03-01), None
patent: WO 99/26921 (1999-06-01), None
patent: WO 01/025219 (2001-04-01), None
patent: WO 02/032867 (2002-04-01), None
patent: WO 02/057233 (2002-07-01), None
patent: WO 04/033428 (2004-04-01), None
Rupniak et al., “Differential Inhibition of foot tapping and chromodacryorrhoea in gerbils by CNS penetrant and non-penetrant tachykinin NK1receptor antagonists,”European Journal of Pharmacology265:179-183 (1994).
Megens, A., et al. J. Pharmacology and Experimental Therapeutics (2002)302(2):696-709.
Challet, E., et al. Neuropharmacology (2001) 40(3): 408-415.
Romerio, et al., Clinical Pharmacology and Therapeutics (1999) 66(5):522-527.
Davis, David T., “Synthesis A. Biological Activity of a Series of Piperazin-2,3-Diones,” Journal of Antibiotics, vol. XLII, No. 3, 1989, pp. 367-373.
Pacher, P., et al. “Review of Cardiovascular Effects of Fluoxetine, A Selective Serotonine Reuptake Inhibitor, Compared to Tricyclic Antidepressants.” Current Medicinal Chemistry, 1998, 5, pp. 381-390.
Alvaro Giuseppe
Maragni Paolo
Tampieri Marsia
Morgan Lorie Ann
Raymond Richard L.
SmithKline Beecham Corporation
LandOfFree
Chemical compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemical compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3695627